17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
The UK Competition and Markets Authority (CMA) has published a document setting out its digital mark...
Read More >
Last month, New Jersey Governor Phil Murphy signed into law the Jake Honig Compassionate Use Medical...
Read More >
On August 7, 2019, U.S. Immigration and Customs Enforcement’s (ICE) Homeland Security Investigation...
Read More >
On August 12, 2019, Governor Andrew Cuomo signed into law S.6577, a bill implementing a series of sw...
Read More >
In this episode of Tarter Krinsky & Drogin's podcast series Law Brief, Non-Competes Are Not So Bad! ...
Read More >
Under Missouri law, a request for accommodation cannot serve as the basis for a retaliation claim. ...
Read More >